Key opinion leaders in the management of relapsing/remitting multiple sclerosis, Enrique Alvarez, MD, PhD and Lawrence Steinman, MD, review key factors to consider when using high-efficacy therapies and provide an overview of emerging data for potential new treatment options.
Diabetes Linked With Increased Levels of Neurofilament Light, Neuroaxonal Damage in Parkinson Disease
Using Functional Connectivity and the Default Network to Uncover Sex-Based Differences: Jessica Caldwell, PhD
NeuroVoices: Vesna Garovic, MD, PhD, on Severe Preclampsia’s Effect on Late-Life Cognition, Neuroinflammation for Women
FDA Extends Review of Omaveloxolone in Friedreich Ataxia